We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$651M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$24.1M
3
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$19.4M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$17.9M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$8.93M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGFY
2751
DELISTED
Signify Health, Inc.
SGFY
$53K ﹤0.01%
1,849
+228
+14% +$6.58K
NCNO icon
2752
nCino
NCNO
$2.08B
$52.5K ﹤0.01%
1,987
-16
-0.8% -$450
TWKS
2753
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$52.4K ﹤0.01%
5,146
-135
-3% -$1.25K
BARK icon
2754
BARK
BARK
$96.3M
$52.4K ﹤0.01%
1,758
-2,024
-54% -$67.3K
CELL
2755
DELISTED
PhenomeX Inc. Common Stock
CELL
$51.8K ﹤0.01%
19,322
-8,507
-31% -$22.4K
OSH
2756
DELISTED
Oak Street Health, Inc.
OSH
$51.8K ﹤0.01%
2,407
+12
+0.5% +$251
LBRDA icon
2757
Liberty Broadband Class A
LBRDA
$5.07B
$51.7K ﹤0.01%
681
-48
-7% -$3.91K
PTON icon
2758
Peloton Interactive
PTON
$2.38B
$50.6K ﹤0.01%
6,369
+157
+3% +$1.51K
WW
2759
DELISTED
WW International
WW
$50K ﹤0.01%
12,953
-16,440
-56% -$65.9K
AHT
2760
Ashford Hospitality Trust
AHT
$19.8M
$49.6K ﹤0.01%
1,109
-740
-40% -$47.7K
RBBN icon
2761
Ribbon Communications
RBBN
$372M
$49.6K ﹤0.01%
17,761
-21,548
-55% -$55.8K
PEAR
2762
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$49.5K ﹤0.01%
+41,941
New +$88.2K
CPA icon
2763
Copa Holdings
CPA
$5.54B
$49.2K ﹤0.01%
592
+2
+0.3% +$157
CANO
2764
DELISTED
Cano Health, Inc.
CANO
$48.5K ﹤0.01%
354
-525
-60% -$178K
NVAX icon
2765
Novavax
NVAX
$1.31B
$48.5K ﹤0.01%
4,717
-124
-3% -$2.19K
FIRY
2766
Firy Inc
FIRY
$156M
$47.7K ﹤0.01%
4,706
-3,855
-45% -$70.9K
CNM icon
2767
Core & Main
CNM
$8.62B
$47.2K ﹤0.01%
2,442
-34
-1% -$724
AZEK
2768
DELISTED
The AZEK Co
AZEK
$46.7K ﹤0.01%
2,298
+11
+0.5% +$204
AKTS
2769
DELISTED
Akoustis Technologies Inc
AKTS
$45.6K ﹤0.01%
16,157
-11,516
-42% -$36.2K
PLTK icon
2770
Playtika
PLTK
$904M
$43.9K ﹤0.01%
5,164
-879
-15% -$8.15K
AFRM icon
2771
Affirm
AFRM
$24.6B
$43.5K ﹤0.01%
4,496
+845
+23% +$12.7K
AMC icon
2772
AMC Entertainment Holdings
AMC
$2.26B
$43.5K ﹤0.01%
1,068
+5
+0.5% +$315
MRTX
2773
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$41.8K ﹤0.01%
922
+37
+4% +$2.39K
LXRX icon
2774
Lexicon Pharmaceuticals
LXRX
$1.05B
$41.7K ﹤0.01%
21,835
-18,221
-45% -$38.8K
DNA icon
2775
Ginkgo Bioworks
DNA
$486M
$41.7K ﹤0.01%
616
+22
+4% +$2.02K
109 110
111
112 113

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.